Over the last decade, Chile has been the most successful Latin American country in reducing the per capita income gap compared to the advanced countries. Chile now needs to further strengthen some institutional pillars of an efficient market-oriented economy, notably its innovation system.
Bringing together over 200 internationally comparable quality indicators to explore the progress of national innovation strategies and recent developments in science, technology and industry.
This paper quantifies and examines the contribution of capital, labour and multifactor productivity (MFP) to GDP growth and analyses the role of measurement of capital and labour inputs for the MFP estimate, using a comprehensive growth accounting exercise for 14 OECD countries.
This study aims at designing simple but robust methods that would enable to "nowcast", i.e. forecast the present (or the recent past), in order to improve the timeliness of patent indicators.
The focus at the OECD on industrial biotechnology is to identify the potential contribution of biotechnology to sustainable growth and development, and identify and appraise policy options for supply and demand side interventions that can drive efficient transition towards bio-based economy.
This comprehensive assessment of the innovation system of South Africa focuses on the role of government, and provides concrete recommendations on how to improve policies which impact on innovation performance, including R&D policies.
The conference, to be held in Dublin on 2 November 2007, will focus upon the emerging discipline of nanotoxicology and its implications to the broader nanotechnology community. Particular emphasis will be given to the food, environment and medical sectors. The conference will bring together a number of international leaders in the area of nanotoxicology and represents the first conference on this novel topic to be held in Ireland. It
Bilingual (English/Spanish) final report on the OECD peer review of Spain’s “policy mix” for research and innovation policies.
Genetics is playing an increasingly important role in health care. New technical advances and information deriving from human genome research are changing health care practices and the economics of healthcare provision.
This paper aims to capture current inventive activities in nanotechnologies based on the analysis of patent applications to the European Patent Office (EPO).